Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
about
Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family CoronaviridaeStructure and inhibition of the SARS coronavirus envelope protein ion channelA sensitive assay for virus discovery in respiratory clinical samplesViral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004-2008.The management of coronavirus infections with particular reference to SARS.Use of sensitive, broad-spectrum molecular assays and human airway epithelium cultures for detection of respiratory pathogensHuman coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genesIdentification and evaluation of a highly effective fusion inhibitor for human metapneumovirusHuman coronavirus NL63, a new respiratory virus.The novel human coronaviruses NL63 and HKU1.Respiratory viral diseases: access to RNA interference therapy.Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirusTherapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.Plaque assay for human coronavirus NL63 using human colon carcinoma cells.Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63β-D-N(4)-hydroxycytidine is a potent anti-alphavirus compound that induces high level of mutations in viral genome.Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
P2860
Q24648487-334EAB9E-2DB0-4211-943B-71FD9C2E742DQ28475712-71F5DC94-707D-4D24-8AF2-C2EE2BD457BFQ33808972-C90E6ACE-C54C-47CE-827C-CC7295F8D395Q33859448-D2C1BE5C-840B-4369-AD95-E21079FA9C57Q34012358-A6DE16A8-6D0B-445B-8CA7-EFF97D450AEBQ34189545-C9CE1E00-3814-4C4A-9B91-5F8E5F9CD86EQ35597534-4ED8CA96-2CBE-4392-9D03-5C92D5B83441Q36422618-6CE2F47C-EBAA-49E2-A808-3EB35D47C14EQ36566597-E5F4CD6C-5EDB-4F47-82FD-3F1433D68914Q36641750-79FF0956-F01C-41E4-905E-BADD919E4FA1Q37350504-1586D6C0-E313-45C1-9CBB-613AF577D924Q37410980-B3B3D0CD-7E26-474E-8144-3EBCBB7F8E8CQ37481314-056DEC90-C891-4A11-9CEA-AE3858B68600Q40035989-2DBCD0C3-6BB0-4EFF-ACBB-DD6D19770621Q41829011-938CBB25-7DD6-4917-AE13-EE1F84F74438Q42737885-B292127D-DCC3-4837-A3E7-FA4FC372B565Q44170252-F05C43B4-4990-4DF0-8E0E-924480CA4DCDQ53704198-81DCD78D-A814-44C9-B675-C138EDBEE535
P2860
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
@en
type
label
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
@en
prefLabel
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
@en
P2093
P2860
P50
P356
P1476
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
@en
P2093
Ben Berkhout
Lia van der Hoek
Maarten F Jebbink
P2860
P304
P356
10.1128/AAC.01598-05
P407
P577
2006-06-01T00:00:00Z